Department of Biological Sciences-Physiology, Cell and Developmental Biology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Tanglin Health Clinic, 50480 Kuala Lumpur, Malaysia.
Curr Med Chem. 2022;29(16):2891-2912. doi: 10.2174/0929867328666210910154330.
There is an increase in the incidence of inflammatory eye diseases worldwide. Several dysregulated inflammatory pathways, including the NOD-like receptor protein 3 (NLRP3) inflammasome, have been reported to contribute significantly to the pathogenesis and progression of ophthalmic diseases. Although the available allopathic/ conventional medicine has demonstrated effectiveness in managing eye diseases, there is an ongoing global demand for alternative therapeutics with minimal adverse drug reactions, easy availability, increase in patient compliance, and better disease outcomes. Therefore, several studies are investigating the utilization of natural products and herbal formulations in impeding inflammatory pathways, including the NLRP3 inflammasome, in order to prevent or manage eye diseases. In the present review, we highlight the recently reported inflammatory pathways with special emphasis on NLRP3 Inflammasomes involved in the development of eye diseases. Furthermore, we present a variety of natural products and phytochemicals that were reported to interfere with these pathways and their underlying mechanisms of action. These natural products represent potential therapeutic applications for the treatment of several inflammatory eye diseases.
全球范围内,炎症性眼病的发病率不断上升。据报道,几种失调的炎症途径,包括 NOD 样受体蛋白 3(NLRP3)炎性小体,对眼科疾病的发病机制和进展有重要贡献。尽管现有的对症/常规医学已证明对眼部疾病的治疗有效,但全球仍在持续寻求具有最小药物不良反应、易于获取、提高患者依从性和更好疾病结局的替代疗法。因此,许多研究正在调查天然产物和草药制剂在抑制炎症途径(包括 NLRP3 炎性小体)方面的应用,以预防或治疗眼部疾病。在本综述中,我们重点介绍了最近报道的炎症途径,特别强调了 NLRP3 炎性小体在眼部疾病发展中的作用。此外,我们还介绍了多种被报道可干扰这些途径及其潜在作用机制的天然产物和植物化学物质。这些天然产物代表了治疗多种炎症性眼病的潜在治疗应用。